Arla's €63m Investment Signals Protein Dairy Category Maturation

Arla Foods' significant €63.3 million investment in expanded Skyr and cottage cheese production capacity signals the continued mainstreaming of high-protein dairy, with direct implications for the broader supplement market. The cooperative is allocating €35 million to Skyr production at its Upahl site in Germany and €28.3 million to cottage cheese facilities in Falkenberg, Sweden. These expansions, anticipated to come online progressively through 2028, respond to substantial market growth; Arla reports Skyr volumes increased over 33% and cottage cheese volumes over 25% across its European markets in the last three years, as reported by Food Ingredients First.

This strategic capital injection reflects a fundamental shift in consumer behaviour: protein is no longer a niche sports nutrition component but a daily dietary staple. Consumers actively seek convenient, protein-rich foods offering satiety and functional benefits. Cottage cheese, in particular, has seen a robust resurgence, with L Catterton acquiring a majority stake in US brand Good Culture, citing a near 60% category rebound.

The investment also highlights the increasing importance of integrated supply chains for high-value dairy. As protein demand intensifies, competition for quality raw milk and processing capacity will escalate. Supplement manufacturers reliant on dairy-derived proteins—such as whey or casein—will experience tighter supply and upward pricing pressure. Arla's commitment to scaling production of these products demonstrates confidence in their long-term market potential, reinforcing the need for supplement brands to secure stable ingredient procurement.

Beyond capacity, the move underscores the evolving definition of protein products. While performance nutrition established protein's value, current trends link it to everyday satiety, active lifestyles, and even weight management, with high-protein dairy like Skyr and cottage cheese gaining traction amidst the rise of GLP-1 weight-loss drugs. This broader appeal necessitates innovative formulation and marketing strategies for supplement brands to capture an expanding consumer base.

What this means for United Kingdom

UK supplement manufacturers will encounter increased competition for dairy protein inputs, potentially compressing margins. Procurement teams must anticipate extended lead times and negotiate long-term supply agreements for whey and casein to mitigate price volatility driven by increased demand from functional food producers. Brand owners have a clear opportunity to reformulate existing products or launch new SKUs emphasising convenience and satiety, leveraging the established consumer understanding of protein's benefits from mainstream dairy products sold by retailers like Tesco and Sainsbury's. Compliance teams should ensure robust substantiation for any protein-related claims, aligning with FSA guidelines.

This dynamic environment requires agility. Brand owners must differentiate beyond protein content, focusing on innovative formats, flavour profiles, and complementary ingredients. Manufacturers should evaluate current MOQs and assess whether co-packing relationships can offer greater flexibility in meeting fluctuating demand for protein-focused product lines. The ongoing shift signals a need for a more integrated product development approach, considering the entire protein ecosystem from raw material to retail shelf.

Brand owners increasingly rely on contract-manufacturing partners such as Supplement Factory to navigate these requirements.